L
Levee Medical
Designs, develops, and manufactures innovative urological devices with the focus of improving recovery outcomes post-prostatectomy
About Levee Medical
Levee Medical is a clinical-stage medical device company focused on improving surgical outcomes for prostate cancer patients. Based in Durham, NC, the company is currently in the research and development phase, working on a novel urologic device called the Voro prostatectomy implant. This bioresorbable post-prostatectomy implant aims to reduce complications, particularly urinary incontinence, which is a common and debilitating issue following prostate cancer surgery.
Levee Medical's primary clients are healthcare providers and institutions that treat prostate cancer patients. The company operates in the medical device market, specifically targeting the urologic segment. Its business model revolves around developing innovative medical devices that can be licensed or sold to hospitals, clinics, and surgical centers once they receive regulatory approval.
The company recently closed an oversubscribed Series A financing round, raising a total of $6.6 million. These funds will be used to advance product development, scale infrastructure, and expand the team. Levee Medical also raised an additional $4.3 million in oversubscribed funds and successfully treated the first study participants in its initial human study, demonstrating the initial safety of its device.
Levee Medical makes money by developing and eventually selling or licensing its medical devices to healthcare providers. The company is committed to enhancing recovery outcomes for prostate cancer patients, allowing them to return to their daily lives with confidence and minimal complications.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Durham, United States
- Employees
- 8
- Open positions
- None listed
- Dealroom signal
- 57.4/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, medical implants, Surgery, Hard Tech, urinary, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Feb 2026 | $12M | $48M | Undisclosed | ↗ |
| SERIES B✓Equity / VC | Feb 2025 | — | — | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Levee Medical is 1.3K monthly website visits, up 622.2% over the last three months. Levee Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Levee Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Levee Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.